Three stage contingent screening for Down syndrome [1]

Prenatal Diagnosis

Volumn 26, Issue 12, 2006, Pages 1183-

  Huttly, Wayne J ^a   Morris, Joan K ^a   Bestwick, Jonathan P ^a   Wald, Nicholas J ^a   Murphy, Karl ^b   Pandya, Pranav P ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOWN SYNDROME; FETUS ECHOGRAPHY; GENETIC RISK; GENETIC SCREENING; GESTATION PERIOD; HUMAN; LETTER; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MULTIPHASIC SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 33845597354     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1579     Document Type: Letter

References (3)

1. Morris JK, Mutton DE, Alberman E 2002. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 9: 2-6.
2. Wald NJ, Rudnicka AR, Bestwick JP. 2006. Sequential and Contingent prenatal screening for Down syndrome 26: 769-777.
3. Wright D, Bradbury I, Cuckle H, et al. 2006. Three-stage contingent screening for Down syndrome. Prenat Diagn (epub ahead of print).